Synthetic toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Shanmugam, Arulkumaran ^a   Rajoria, Shilpi ^a   George, Andrea L ^a   Mittelman, Abraham ^a   Suriano, Robert ^a   Tiwari, Raj K ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4; AUTACOID; IMMUNOLOGICAL ADJUVANT; PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; INNATE IMMUNITY; MACROPHAGE; MOUSE; NONHUMAN; PHAGE DISPLAY; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; CELL NUCLEUS; CELL STRAIN HEK293; CHEMISTRY; DRUG EFFECT; DRUG POTENTIATION; HUMAN; METABOLISM; MOLECULAR GENETICS; PROTEIN TRANSPORT; SECRETION;

ADJUVANTS, IMMUNOLOGIC; AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CELL NUCLEUS; CYTOKINES; HEK293 CELLS; HUMANS; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PEPTIDES; PROTEIN TRANSPORT; TOLL-LIKE RECEPTOR 4;

EID: 84857383991     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030839     Document Type: Article

References (32)

1. Beveridge TJ, (2001) Use of the gram stain in microbiology. Biotech Histochem 76: 111-118.
2. Janeway CA Jr, Medzhitov R, (2002) Innate immune recognition. Annu Rev Immunol 20: 197-216.
3. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F, (1999) Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 274: 10689-10692.
4. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, et al. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303-1310.
5. Sasse KC, Nauenberg E, Long A, Anton B, Tucker HJ, et al. (1995) Long-term survival after intensive care unit admission with sepsis. Crit Care Med 23: 1040-1047.
6. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, et al. (2001) Recombinant human protein C Worldwide Evaluation in Severe sepsis (PROWESS) study group, efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344: 699-709.
7. Bochud PY, Calandra T, (2006) Pathogenesis of sepsis: new concepts and implications for further treatment. BMJ 326: 262-266.
8. Hack CE, Aarden LA, Thijs LG, (1997) Role of cytokines in sepsis. Adv Immunol 66: 101-195.
9. Riedemann NC, Guo RF, Ward PA, (2003) Novel strategies for the treatment of sepsis. Nat Med 9: 517-524.
10. Means TK, Golenbock DT, Fenton MJ, (2000) Structure and function of Toll-like receptor proteins. Life Sci 68: 241-258.
11. Stoll LL, Denning GM, Weintraub NL, (2006) Endotoxin, TLR4 signaling and vascular inflammation: potential therapeutic targets in cardiovascular disease. Curr Pharm Des 12: 4229-4245.
12. Hashimoto C, Hudson KL, Anderson KV, (1988) The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein. Cell 52: 269-279.
13. Kim HM, Park BS, Kim JI, Kim SE, Lee J, et al. (2007) Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130: 906-917.
14. O'Neill LA, Bowie AG, (2007) The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 7: 353-364.
15. Schijns VE, (2000) Immunological concepts of vaccine adjuvant activity. Curr Opin Immunol 12: 456-63.
16. Kaisho T, Akira S, (2002) Toll-like receptors as adjuvant receptors. Biochim Biophys Acta 1589: 1-13.
17. Huleatt JW, Jacobs AR, Tang J, Desai P, Kopp EB, et al. (2007) Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity. Vaccine 25: 763-775.
18. Nempont C, Cayet D, Rumbo M, Bompard C, Villeret V, et al. (2008) Deletion of flagellin's hypervariable region abrogates antibody-mediated neutralization and systemic activation of TLR5-dependent immunity. J Immunol 181: 2036-2043.
19. Douagi I, Gujer C, Sundling C, Adams WC, Smed-Sörensen A, et al. (2009) Human B cell responses to TLR ligands are differentially modulated by myeloid and plasmacytoid dendritic cells. J Immunol 182: 1991-2001.
20. Wille-Reece U, Flynn BJ, Loré K, Koup RA, Kedl RM, et al. (2005) HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates. Proc Natl Acad Sci USA 102: 15190-15194.
21. Schneerson R, Fattom A, Szu SC, Bryla D, Ulrich JT, et al. (1991) Evaluation of monophosphoryl lipid A (MPL) as an adjuvant. Enhancement of the serum antibody response in mice to polysaccharide-protein conjugates by concurrent injection with MPL. J Immunol 147: 2136-2140.
22. Casella CR, Mitchell TC, (2008) Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant. Cell Mol Life Sci 65: 3231-3240.
23. Hou Y, Gu XX, (2003) Development of peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccine candidates. J Immunol 170: 4373-4379.
24. Parmley SF, Smith GP, (1988) Antibody-selectable filamentous fd Phage vectors: affinity purification of target genes. Gene 73: 305-318.
25. Smith GP, Scott JK, (1993) Libraries of peptides and proteins displayed on filamentous Phage. Methods Enzymol 217: 228-257.
26. Shanmugam A, Suriano R, Goswami N, Chaudhuri D, Ashok BT, et al. (2011) Identification of peptide mimotopes of gp96 using single-chain antibody library. Cell Stress Chaperones 16: 225-234.
27. Harris J, Sharp FA, Lavelle EC, (2010) The role of inflammasomes in the immunostimulatory effects of particulate vaccine adjuvants. Eur J Immunol 40: 634-638.
28. Wilson-Welder JH, Torres MP, Kipper MJ, Mallapragada SK, Wannemuehler MJ, et al. (2009) Vaccine adjuvants: current challenges and future approaches. J Pharm Sci 98: 1278-316.
29. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr, (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 24: 394-397.
30. Cinel I, Opal SM, (2009) Molecular biology of inflammation and sepsis: a primer. Crit Care Med 37: 291-304.
31. Leung JY, Chapman JA, Harris JA, Hale D, Chung RS, et al. (2008) Olfactory ensheathing cells are attracted to, and can endocytose, bacteria. Cell Mol Life Sci 65: 2732-2739.
32. Ellett JD, Atkinson C, Evans ZP, Amani Z, Balish E, et al. (2010) Murine kupffer cells are protective in total hepatic ischemia/reperfusion injury with bowel congestion through IL-10. J Immunol 184: 5849-5858.